Persistent Depressive Disorder (PDD), also known as dysthymia, is a mental health disorder characterized by a chronic low mood that lasts for a prolonged period of time. Here is a more detailed description of the disorder and its presentation:

People with PDD experience a consistently depressed mood more days than not for a prolonged duration. Unlike Major Depressive Disorder (MDD), where symptoms can be severe but might be limited to distinct episodes, the symptoms of PDD tend to be less severe but more chronic and persistent.

In adults, the depressive mood must be present for at least two years, whereas for children and adolescents, the mood must be present for at least one year. Even if the mood disturbance lifts, periods without depressive symptoms usually last no longer than two months.

People with Persistent Depressive Disorder (PDD) often manifest a range of symptoms that profoundly affect their daily lives. One of the most prominent feelings they grapple with is a sense of low self-esteem, leading them to see themselves negatively and harbor beliefs that they are inadequate or perpetually in the wrong. This is frequently accompanied by a deep-seated feeling of hopelessness, a conviction that their circumstances will remain unchanging and that the future holds no promise. These emotional burdens often translate into physiological manifestations, such as changes in appetite—either a loss or a tendency to overeat. Sleep patterns are commonly disrupted, with individuals either struggling with insomnia or feeling the need to sleep excessively.

Fatigue becomes a constant companion for many, draining their energy for even the most mundane tasks. This weariness is often coupled with a diminished capacity to concentrate, making decision-making challenging and leading to avoidance of tasks requiring focus. Such symptoms often result in a gradual retreat from social scenarios. Those with PDD may feel out of place or worry that their mood dampens the spirits of those around them. Their overall productivity, whether at work, school, or home, tends to diminish, a decline fueled by the combined effects of hopelessness, fatigue, and impaired concentration.

Some also report physical complaints without a discernible cause—mysterious aches or pains unrelated to injury or illness. Notably, while adults with PDD present many of these symptoms, children and adolescents might predominantly display irritability. Younger individuals often seem persistently grouchy or may have regular temper tantrums.

It is essential to understand that the presentation can vary significantly among individuals. Some might function reasonably well, maintaining jobs and relationships, while still feeling persistently "down" or unhappy. Others may struggle to carry out daily routines and responsibilities because of their mood. Also, PDD can exist alongside other mental health disorders, adding complexity to its presentation.

Diagnostic Criteria

Persistent Depressive Disorder (PDD), commonly known as dysthymia, has specific diagnostic criteria in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). According to the DSM-5, the diagnostic criteria for PDD are as follows:

• A depressed mood for most of the day, more days than not, as indicated by either subjective account or observation by others, for at least two years.
• The presence of Two (or more) of the following:

• Poor appetite or overeating
• Insomnia or hypersomnia
• Low energy or fatigue
• Low self-esteem
• Poor concentration or difficulty making decisions
• Feelings of hopelessness

• During the two years of the disturbance, any symptom-free intervals last no longer than two months at a time.
• Major depressive disorder criteria have not been met during the first two years of the disturbance.
• No manic or hypomanic episode has been observed.
• The disturbance is not better explained by a persistent schizoaffective disorder, schizophrenia, delusional disorder, or another specified or unspecified schizophrenia spectrum and other psychotic disorders.
• The symptoms are not attributable to the physiological effects of a substance (e.g., a drug of abuse, medication) or another medical condition.
• The symptoms cause clinically significant distress or impairment in social, occupational, or other essential areas of functioning.

Persistent Depressive Disorder (PDD), often called dysthymia, is a type of long-lasting sadness or depression. If someone has PDD, they feel down or depressed for most of the day, almost every day, for at least two years. During this time, they might also have some of these issues: eating too much or too little, sleeping too much or too little, feeling tired a lot, not feeling good about themselves, finding it hard to concentrate or make decisions, and feeling like there is no hope for the future. Even if they occasionally feel okay, these good times do not last longer than two months. This is not the same as the deep depression that comes and goes; it is a lighter but more long-term kind of sadness. Drugs, medications, or other medical problems do not cause it. Furthermore, it is not part of another mental condition. Also, it is important to remember that only a trained doctor or therapist can diagnose someone with PDD, but these are the general guidelines they use (American Psychiatric Association, 2013).

The Impacts

Persistent Depressive Disorder (PDD), also known as dysthymia, can have profound and lasting effects on an individual's life. People with PDD often experience chronic sadness and hopelessness, which can infiltrate various aspects of their daily existence. This continuous low mood can undermine self-worth, leading to an enduring sense of inadequacy and a negative self-perception (Klein et al., 2018). Consequently, individuals with PDD may struggle with forming and maintaining interpersonal relationships due to their reduced self-esteem and heightened sensitivity to rejection or criticism (Lara et al., 2000).

Further, their consistently low mood can hinder occupational and academic performance, not only due to decreased motivation but also because of impaired concentration and decision-making abilities. This can lead to lower achievements and increased job turnover, adding financial stress to the emotional burden (Gilmer et al., 2005). Moreover, physical health can also be compromised. Evidence suggests that people with PDD are at an increased risk of developing chronic health conditions, like cardiovascular diseases, possibly due to prolonged stress and potential neglect of health-promoting behaviors (Lasserre et al., 2016).

Finally, the persistent nature of PDD makes individuals vulnerable to developing comorbid disorders, such as anxiety disorders, substance abuse, or even major depressive episodes, further complicating their mental health landscape and complicating treatment (Kessler et al., 1997). As such, PDD's long-term nature and wide-ranging impact necessitate timely intervention and support.

The Etiology (Origins and Causes)

Persistent Depressive Disorder (PDD), or dysthymia, is a complex condition with multifaceted etiology. Like most mood disorders, the origins and causes of PDD arise from a combination of biological, psychological, and environmental factors.

Biologically, research indicates that individuals with PDD may have alterations in their neurotransmitter function, particularly involving serotonin, which is instrumental in mood regulation (Juruena et al., 2007). Brain imaging studies have also suggested structural and functional abnormalities in regions associated with mood regulation, such as the prefrontal cortex and the amygdala (Lacerda et al., 2003).

Genetics play a role, too. A family history of depressive disorders increases the risk of developing PDD, implying a hereditary predisposition (Klein et al., 2004). However, no single "depression gene" has been identified; instead, multiple genes likely contribute to susceptibility.

Psychologically, certain personality traits or thinking patterns can predispose individuals to PDD. For instance, a persistent pessimistic outlook, chronic low self-esteem, or a tendency towards perfectionism can increase vulnerability (Hankin & Abramson, 2001). Early life experiences, especially chronic exposure to stressful events or trauma during childhood, are significant risk factors. Childhood adversities, such as the loss of a parent, emotional neglect, or physical abuse, can set the stage for developing PDD later in life (Heim & Nemeroff, 2001).

Environmentally, ongoing exposure to stressors, including relationship difficulties, financial strain, or chronic illnesses, can maintain or exacerbate PDD symptoms. Socioeconomic factors, like prolonged poverty, can also heighten the risk (Gilman et al., 2003).

The origins and causes of PDD are intricate and often interwoven, requiring a biopsychosocial approach to understanding its etiology.

Comorbidities

Persistent Depressive Disorder (PDD), also known as dysthymia, is frequently accompanied by other mental health disorders or conditions, a phenomenon termed comorbidity. The presence of comorbid conditions can complicate the clinical picture and influence the course and treatment of PDD.

Anxiety Disorders: PDD often co-occurs with various anxiety disorders. Patients with PDD are particularly susceptible to generalized anxiety disorder (GAD), panic disorder, and social anxiety disorder (Markowitz et al., 2007). The overlap between depressive and anxiety symptoms can amplify the severity and persistence of each disorder.

Major Depressive Disorder (MDD): Individuals with PDD can experience episodes of major depression on top of their chronic low mood. This phenomenon is sometimes referred to as "double depression" (Keller & Boland, 1998). These episodes can intensify the distress and functional impairment associated with PDD.

Substance Use Disorders: People with PDD have an increased risk for substance abuse or dependence. The misuse of alcohol or drugs might be an attempt to self-medicate or manage the chronic depressive symptoms but can, in turn, worsen the course of PDD and create additional health concerns (Rhebergen et al., 2014).

Personality Disorders: PDD is often comorbid with certain personality disorders, especially avoidant, borderline, and dependent personality disorders. These personality styles can exacerbate the challenges faced by those with PDD and influence the pattern of interpersonal relationships and coping strategies (Skodol et al., 1999).

Physical Health Comorbidities: Apart from mental health disorders, PDD has been associated with an increased risk of chronic physical conditions, such as cardiovascular disease, diabetes, and chronic pain disorders (Penninx et al., 2013). The interplay between chronic low mood and physical health issues can further deteriorate the quality of life.

In summary, the presence of comorbid conditions with PDD underscores the complexity of this disorder and emphasizes the need for comprehensive assessment and treatment.

Risk Factors

These risk factors for PDD span biological, psychological, and environmental origins. An individual's genetic makeup and family history can influence the predisposition to PDD. Those with a first-degree relative who has experienced any form of depressive disorder may be at a higher risk (Klein et al., 2004).

Differences in brain chemistry or structure, particularly in regions associated with mood regulation, might predispose specific individuals to PDD. Dysregulated neurotransmitter systems, especially involving serotonin, may contribute (Juruena et al., 2007).

Experiences of trauma or adversity during childhood, such as abuse, neglect, or the loss of a parent, can set the stage for developing PDD in later life (Heim & Nemeroff, 2001). Ongoing exposure to stress, be it relational, financial, or occupational, can heighten vulnerability to PDD. Chronic stress can have wear-and-tear effects on mood and overall well-being (Hammen, 2005). Living with chronic or severe medical conditions, such as heart disease or cancer, can increase the risk of developing depressive disorders, including PDD (Evans et al., 2005).

While many risk factors for PDD exist, their presence does not necessarily guarantee the onset of the disorder. A combination of factors, often interacting in complex ways, contributes to its development.

Personalty Risk Factors

Individuals with certain personality traits, such as high neuroticism, pessimism, or excessive reliance on others for validation or support, may be more susceptible to PDD (Hankin & Abramson, 2001).

High Neuroticism: Neuroticism is a personality trait characterized by a propensity to experience negative emotions such as anxiety, sadness, anger, and emotional instability. Individuals high in neuroticism are more reactive to stressors, have amplified emotional responses, and may ruminate more on negative experiences. This heightened emotional reactivity and frequent experience of negative emotions can set the stage for the onset of depressive disorders like PDD (Ormel et al., 2004). The chronic nature of their negative emotional states might make them more vulnerable to persistent, low-grade depressive moods.

Pessimism: Pessimism is the tendency to view the future negatively and expect unfavorable outcomes. Pessimistic individuals often interpret situations with a negative bias and anticipate failures or hardships. This continual negative outlook can feed into feelings of hopelessness, a significant feature of depressive disorders. Hankin and Abramson's (2001) work on cognitive vulnerabilities highlighted that a pessimistic explanatory style can be a risk factor for depression, wherein individuals attribute adverse events to stable (it will always be this way) and global (it affects everything) causes.

Excessive Reliance on Others for Validation or Support: Some individuals might rely heavily on external validation or approval to maintain self-worth and emotional well-being. Such a dependency on external affirmation can make one's self-esteem and mood vulnerable to external factors. When they do not receive the expected validation or if they encounter criticism, they might experience significant emotional dips. Over time, this constant need for external validation and the emotional roller-coaster tied to it can increase the risk of PDD (Shahar & Davidson, 2003). Additionally, excessively relying on others can lead to interpersonal issues, which may further contribute to depressive symptoms if one perceives themselves as a burden or feels chronically unappreciated.

Research has identified that a constellation of personality traits can influence how an individual perceives, interprets, and reacts to life events and stressors. Over time, these cognition, emotion, and behavior patterns can elevate the risk of developing persistent depressive symptoms characteristic of PDD.

Case Study

Background: Maria is a 38-year-old single woman working as a middle school teacher. She has a long-standing history of feeling "just below the baseline" regarding mood. Her colleagues often describe her as reserved, and her family notices that she is rarely truly happy or excited about events that usually bring joy to others.

Presenting Issue: Maria came to therapy after noticing a declining interest in social activities and a pervasive hopelessness about her future. She reported not feeling genuinely happy in the past few years. She states, "I am not acutely sad, but I cannot remember the last time I was really happy."

History: Upon deeper assessment, it was revealed that Maria's low mood started in her late teens. While she did not experience major depressive episodes, her chronic low mood persisted for years. Her feelings of inadequacy often overshadowed her academic achievements, and a constant fear of rejection marked her relationships.

Symptoms: Maria reported sleep disturbances, often struggling to fall asleep, ruminating on minor past mistakes, or worrying about potential future failures. She also noticed a reduced appetite and sometimes had to force herself to eat. Maria struggles with making decisions, even minor ones like choosing a meal at a restaurant, for fear of making the "wrong" choice. Her teaching job, which she was once passionate about, now felt like a chore. She reported feeling fatigued most of the time, regardless of how much sleep she got.

Course of Treatment: Maria entered cognitive-behavioral therapy (CBT), a form of psychotherapy effective for PDD. The therapy focused on challenging and reframing her negative thought patterns, developing coping mechanisms to manage her symptoms, and setting small goals to reintroduce pleasure and mastery in her daily life.

Additionally, after a thorough assessment and consultation with a psychiatrist, Maria was prescribed a low SSRI (Selective Serotonin Reuptake Inhibitor) to manage her symptoms.

Outcome: Over the course of 12 months, with consistent therapy and medication management, Maria reported a gradual improvement in her mood and overall well-being. She started engaging in social activities, joined a book club, and began planning a vacation, something she had not considered in years. While she still has days where her mood is low, they are less frequent, and she feels equipped with the tools to manage them.

Recent Psychology Research Findings

Researchers have been keen to understand PDD's underpinnings, comorbidities, and best treatment practices. Several pivotal studies have emerged over the past few years, offering fresh insights into the disorder's neurobiological, cognitive, and psychosocial dimensions.

Studies using neuroimaging techniques have shown that individuals with PDD may have differences in brain structure and function, especially in emotion regulation and processing areas. One study found that PDD patients had altered activity in the amygdala, a region of the brain associated with emotional processing, compared to healthy controls (Lichenstein et al., 2016). The discovery of differences in brain structure and function among PDD patients provides a more concrete basis for the symptoms they experience. By identifying altered activity in the amygdala, an area pivotal for emotion processing, researchers can infer that the emotional symptoms of PDD have tangible neurobiological underpinnings. This lends more credibility to the diagnosis and offers potential targets for therapeutic interventions or medication.

Cognitive vulnerabilities, particularly rumination and negative cognitive style, are prevalent among individuals with PDD. A study by Aldao, Nolen-Hoeksema, and Schweizer (2010) found that rumination, or the repetitive focus on negative feelings and thoughts, was strongly associated with persistent depressive symptoms in PDD. Recognizing the prevalence of rumination and a negative cognitive style among PDD patients helps clinicians anticipate and target these maladaptive patterns during therapy. It underscores that PDD is about pervasive low mood and how individuals process, interpret, and dwell on information and experiences. This finding reinforces the need for cognitive therapies that challenge and reshape these thought patterns.

There is growing evidence that combining cognitive-behavioral therapy (CBT) and medication might be effective for many individuals with PDD. Moreover, research by Keller et al. (2016) highlighted the importance of long-term treatment, as PDD symptoms can be enduring and may not respond quickly to interventions. By confirming the efficacy of combined treatments, like CBT and medication, for PDD, the research paves the way for more standardized and effective treatment protocols. The emphasis on long-term treatment also alerts clinicians and patients alike to be patient, setting realistic expectations about recovery trajectories.

A growing body of research has been investigating the comorbidities associated with PDD. One study suggested that individuals with PDD are at an increased risk of developing anxiety disorders, substance use disorders, and other mood disorders over their lifetime (Skodol et al., 2011). The research on comorbidities associated with PDD is crucial for comprehensive patient care. Understanding that a PDD patient is at higher risk for anxiety disorders or substance use can guide clinicians' assessments and treatment planning. This knowledge aids in a holistic approach, ensuring that all facets of a patient's mental health are considered and addressed.

The link between early childhood adversity and PDD has gained attention. Research by Mandelli, Petrelli, and Serretti (2015) indicated that individuals who experienced childhood traumas, like emotional abuse or neglect, were more likely to develop PDD later in life than major depressive disorder. Highlighting the link between childhood trauma and later development of PDD has significant implications for prevention and early intervention. It highlights the long-lasting impact of early adversities and underscores the importance of support systems, counseling, and interventions for children undergoing trauma. Furthermore, it can help clinicians trace back the origins of the disorder in adults, offering a more contextualized therapeutic approach.

Treatment and Interventions

Persistent Depressive Disorder (PDD), given its chronic nature, necessitates a multi-faceted treatment approach tailored to the individual. Effective treatment often involves a combination of psychotherapy, medication, and lifestyle interventions:

Psychotherapy:

• Cognitive-Behavioral Therapy (CBT) focuses on identifying and challenging negative thought patterns and behaviors. By teaching individuals new skills to combat depressive symptoms, CBT can be beneficial for addressing the cognitive vulnerabilities seen in PDD, such as rumination and negative cognitive styles.
• Interpersonal Therapy (IPT): This modality centers on improving interpersonal relationships and communication patterns. It can benefit individuals with PDD who struggle with interpersonal conflicts or feelings of isolation.
• Psychodynamic Therapy: This approach delves into unconscious feelings and past experiences to unearth and address deeper emotional conflicts that might contribute to PDD.
• Support Groups: Group therapy can provide a platform for individuals with PDD to share experiences, gain insights, and foster community and understanding.

Medication:

• Antidepressants: Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine and paroxetine, and serotonergic-noradrenergic reuptake inhibitors (SNRIs), like duloxetine and venlafaxine, are commonly prescribed. They work by regulating neurotransmitters that influence mood.
• Tricyclic Antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs) can also be used, especially in cases where SSRIs and SNRIs are ineffective. However, they might have more side effects.
• Augmentation Strategies: In some cases, medications like antipsychotics, mood stabilizers, or even stimulants may be added to the primary antidepressant to boost its effect.

Lifestyle Interventions:

• Exercise: Regular physical activity can elevate mood and alleviate depressive symptoms by promoting the release of endorphins.
• Diet: A balanced diet, rich in omega-3 fatty acids, vitamin D, and B vitamins, can support mental well-being.
• Sleep Hygiene: Maintaining a consistent sleep schedule and creating a conducive sleep environment can be essential given the sleep disturbances seen in PDD.
• Stress Reduction Techniques: Practices like mindfulness, meditation, and deep breathing exercises can help manage stress, a potential trigger or exacerbator of depressive symptoms.

Adjunctive Treatments:

• Light Therapy: For those with a seasonal pattern of depression, exposure to bright light can be effective.
• Biofeedback: This technique teaches individuals to control physiological functions, helping them be more attuned to their body's responses and managing symptoms better.

Monitoring and follow-up are crucial in the treatment of PDD. Due to its chronic nature, symptoms can wax and wane, and ongoing assessment ensures that treatment is adjusted according to the patient's needs. Collaborative care involving the individual, their family, and the treatment team yields the best outcomes.

Implications if Untreated

Persistent Depressive Disorder (PDD), if left untreated, can lead to a range of adverse consequences that permeate various domains of an individual's life. The chronic nature of the disorder, marked by its long duration but less severe symptoms compared to major depression, can subtly yet profoundly impact one's well-being, social relationships, and overall quality of life.

• Worsening Mental Health: Without treatment, the symptoms of PDD can become more severe over time. Although PDD is characterized by a more persistent but milder form of depression, the cumulative effect of ongoing depressive symptoms can lead to a significant decline in mental health (Klein et al., 2009).
• Physical Health Decline: Individuals with untreated PDD may experience worsening physical health, including sleep disturbances, chronic pain, and other health complications. Depression has been associated with an increased risk of chronic diseases like heart disease (Penninx et al., 2001).
• Impaired Social and Occupational Functioning: PDD can lead to withdrawal from social situations, resulting in isolation and deteriorating relationships. Occupational functioning can also be compromised, leading to reduced productivity, absenteeism, and challenges in career progression (Gilmer et al., 2005).
• Increased Risk of Comorbidities: Without appropriate intervention, individuals with PDD are at a heightened risk of developing comorbid psychological disorders like anxiety disorders, substance use disorders, and even more severe forms of depression (Skodol et al., 2011).
• Reduced Quality of Life: The persistent nature of PDD, combined with its range of symptoms, can severely impact an individual's overall quality of life, affecting daily activities, self-esteem, and general life satisfaction (Hays et al., 1995).
• Suicidal Ideation and Behaviors: Untreated PDD can increase the risk of suicidal thoughts and behaviors. While PDD may present with less severe symptoms than major depression, the prolonged duration of the disorder can amplify feelings of hopelessness and despair (Klein et al., 2009).

In conclusion, the implications of leaving PDD untreated are extensive and multifaceted. The disorder's enduring nature and pervasive effects emphasize the importance of early recognition and intervention to prevent these adverse outcomes and enhance the individual's prospects for recovery and well-being.

Summary

Depression's various forms and manifestations remain a significant public health concern. Persistent Depressive Disorder (PDD), or dysthymia, represents a chronic and enduring form of depression that often flies under the radar due to its less severe but longer-lasting symptoms. While significant depression garners much attention, the prevalence of conditions like PDD reminds us of the broad spectrum of depressive disorders that exist and the countless individuals they affect.

Identifying and treating PDD is paramount, not just because of its consequences but also due to its cumulative societal impact. The chronic nature of PDD means that individuals grapple with its effects daily, impacting their well-being, relationships, productivity, and overall quality of life. As such, the importance of early identification must be considered. Early intervention facilitates better outcomes, reduces the burden of disease, and fosters more fulfilling lives.

Thankfully, societal perspectives on depression have shifted considerably over the years. What was once a taboo subject shrouded in stigma has become more openly discussed and accepted. Public awareness campaigns, celebrity testimonies, and increased representation in media have played pivotal roles in this transformation. This growing social acceptance has not only demystified depression but has also provided a supportive environment for those affected. Recognizing and legitimizing the experiences of individuals with depression encourages early help-seeking behaviors and reduces feelings of isolation.

Moreover, as awareness has grown, so too has empowerment. With increased knowledge and resources, individuals are better equipped to seek help, understand their condition, and take proactive steps toward recovery. They're more informed about therapeutic options, lifestyle changes, and community support. This empowerment is a testament to the profound change that can occur when society acknowledges, understands, and supports its members.

In conclusion, while the prevalence of PDD and depression is concerning, the strides we've made in recognizing, treating, and accepting these conditions are commendable. As awareness spreads, we forge a path toward a future where mental health is treated with the same urgency, compassion, and understanding as physical health. Everyone deserves the opportunity to lead a life unburdened by the shadows of untreated depression.

References

Aldao, A., Nolen-Hoeksema, S., & Schweizer, S. (2010). Emotion-regulation strategies across psychopathology: A meta-analytic review. Clinical Psychology Review, 30(2), 217-237.

Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R., ... & Valvo, W. J. (2005). Mood disorders in the medically ill: scientific review and recommendations. Biological Psychiatry, 58(3), 175-189.

Gilman, S. E., Kawachi, I., Fitzmaurice, G. M., & Buka, L. (2003). Socioeconomic status in childhood and the lifetime risk of major depression. International Journal of Epidemiology, 32(2), 359-367.

Gilmer, W. S., Trivedi, M. H., Rush, A. J., & Wisniewski, S. R. (2005). Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatrica Scandinavica, 112(6), 425-433.

Hammen, C. (2005). Stress and depression. Annual Review of Clinical Psychology, 1, 293-319.

Hankin, B. L., & Abramson, L. Y. (2001). Development of gender differences in depression: An elaborated cognitive vulnerability–transactional stress theory. Psychological Bulletin, 127(6), 773.

Heim, C., & Nemeroff, C. B. (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies. Biological Psychiatry, 49(12), 1023-1039.

Juruena, M. F., Cleare, A. J., & Young, A. H. (2007). The role of serotonin in the neurobiology of depression: therapeutic implications for mood disorders. Journal of Psychopharmacology, 21(8), 774-791.

Keller, M. B., & Boland, R. J. (1998). Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biological Psychiatry, 44(5), 348-360.

Keller, M. B., Lavori, P. W., Mueller, T. I., Endicott, J., Coryell, W., Hirschfeld, R. M., & Shea, T. (2016). Time to recovery, chronicity, and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects. Archives of General Psychiatry, 49(10), 809-816.

Kessler, R. C., Zhao, S., Blazer, D. G., & Swartz, M. (1997). Prevalence, correlates, and course of minor depression and major depression in the national comorbidity survey. Journal of Affective Disorders, 45(1-2), 19-30.

Klein, D. N., Lewinsohn, P. M., Rohde, P., & Seeley, J. R. (2004). Family study of chronic depression in a community sample of young adults. American Journal of Psychiatry, 161(4), 646-653.

Klein, D. N., Shankman, S. A., Rose, S., & Eaton, W. W. (2018). Subthreshold depressive disorder in adolescents: predictors of escalation to full-syndrome depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 49(7), 703-710.

Lacerda, A. L., Keshavan, M. S., Hardan, A. Y., Yorbik, O., Brambilla, P., Sassi, R. B., ... & Soares, J. C. (2003). Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biological Psychiatry, 55(4), 353-358.

Lara, M. E., Klein, D. N., & Kasch, K. L. (2000). Psychosocial predictors of the short-term course and outcome of major depression: a longitudinal study of a nonclinical sample with recent-onset episodes. Journal of Abnormal Psychology, 109(4), 644.

Lasserre, A. M., Glaus, J., Vandeleur, C. L., Marques-Vidal, P., Vaucher, J., Bastardot, F., ... & Preisig, M. (2016). Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study. JAMA Psychiatry, 73(8), 886-894.

Lichenstein, S. D., Verstynen, T., & Forbes, E. E. (2016). Adolescent brain development and depression: A case for the importance of connectivity of the anterior cingulate cortex. Neuroscience & Biobehavioral Reviews, 70, 271-287.

Mandelli, L., Petrelli, C., & Serretti, A. (2015). The role of specific early trauma in adult depression: A meta-analysis of published literature. Childhood trauma and adult depression. European Psychiatry, 30(6), 665-680.

Markowitz, J. C., Skodol, A. E., Petkova, E., Xie, H., & Cheng, J. (2007). Longitudinal comparison of depressive personality disorder and dysthymic disorder. Comprehensive Psychiatry, 48(4), 353-361.

Ormel, J., Rosmalen, J., & Farmer, A. (2004). Neuroticism: a non-informative marker of vulnerability to psychopathology. Social Psychiatry and Psychiatric Epidemiology, 39(11), 906-912.

Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013). Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Medicine, 11(1), 129.

Rhebergen, D., Batelaan, N. M., de Graaf, R., Nolen, W. A., Spijker, J., Beekman, A. T., & Penninx, B. W. (2014). The 7-year course of depression and anxiety in the general population. Acta Psychiatrica Scandinavica, 129(3), 187-196.

Shahar, G., & Davidson, L. (2003). Depressive symptoms erode self-esteem in severe mental illness: A three-wave, cross-lagged study. Journal of Consulting and Clinical Psychology, 71(5), 890.

Skodol, A. E., Grilo, C. M., Keyes, K. M., Geier, T., Grant, B. F., & Hasin, D. S. (2011). Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. American Journal of Psychiatry, 168(3), 257-264.

Skodol, A. E., Stout, R. L., McGlashan, T. H., Grilo, C. M., Gunderson, J. G., Shea, M. T., ... & Bender, D. S. (1999). Co-occurrence of mood and personality disorders: a report from the Collaborative Longitudinal Personality Disorders Study (CLPS). Depression and Anxiety, 10(4), 175-182.

Gilmer, W. S., Walker, E. F., Johnson, C. J., Philis-Tsimikas, A., & Unützer, J. (2005). Impact of comorbid depression on health-related quality of life among adults with diabetes. Diabetic Medicine, 22(5), 612-617.

Hays, R. D., Wells, K. B., Sherbourne, C. D., Rogers, W., & Spritzer, K. (1995). Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Archives of General Psychiatry, 52(1), 11-19.

Klein, D. N., Shankman, S. A., Lewinsohn, P. M., & Seeley, J. R. (2009). Subthreshold depressive disorder in adolescents: Predictors of escalation to full-syndrome depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 48(7), 703-710.

Penninx, B. W., Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Deeg, D. J., & Wallace, R. B. (2001). Depressive symptoms and physical decline in community-dwelling older persons. Jama, 279(21), 1720-1726.

Skodol, A. E., Grilo, C. M., Keyes, K. M., Geier, T., Grant, B. F., & Hasin, D. S. (2011). Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. American Journal of Psychiatry, 168(3), 257-264.